Upload
buithu
View
214
Download
0
Embed Size (px)
Citation preview
ON
Plot No. 2-D1, Obadenahalli, 3rd
Phase KIADB Industrial Area,
Doddaballapur taluk, Bangalore Rural District – 561 205, Karnataka State.
Table of Contents
1. EXECUTIVE SUMMARY
2. INTRODUCTION OF THE PROJECT/ BACKGROUND INFORMATION
3. PROJECT DESCRIPTION
4. SITE ANALYSIS
5. PLANNING
6. PROPOSED INFRASTRUCTURE
7. REHABILITATION AND RESETTLEMENT (R&R) PLAN
8. PROJECT SCHEDULE & COST ESTIMATION
9. ANALYSIS OF PROPOSAL (FINAL RECOMMENDATION)
1. Executive Summary
M/s STELIS Biopharma Pvt. Ltd., is setting up a new biopharmaceutical facility to manufacture
Monoclonal Antibodies and Therapeutic Proteins.
This industry is promoted by director Shri Joe Thomas.
The plant is proposed to construct in about 10 acres of land.
Products to be manufactured are
1. Monoclonal Antibodies
2. Therapeutic Proteins.
The Company requires 3500 KVA power for the proposed project. The company also proposes
to install 3 no’s of DG sets for standby arrangement during emergency only.
The source of water is from KIADB. The unit requires about 150 KLD during the operational
phase.
Zero discharge effluent treatment plant along with kill system is provided. The Company
proposes to have an Effluent Treatment Plant (ETP) within the premises.
The plant locational advantages regarding the infrastructural facilities like power, water, and
roads are fully developed and connected to National Highways.
The total estimated cost of the project is Rs. 248.00 Crores.
4
2. Introduction of the Project/ Background Information
2.1 Identification of project and project proponent
M/s STELIS Biopharma Pvt. Ltd., is located at Plot No. 2-D1, Obadenahalli, 3rd
Phase
KIADB Industrial Area, Doddaballapur taluk, Bangalore Rural District – 561 205,
Karnataka State. M/s STELIS Biopharma Pvt. Ltd. is proposing to construct biopharmaceutical
facilities to manufacture Monoclonal Antibodies and Therapeutic Proteins.
2.2 Promoters
The affairs of the company are being managed by the director Shri Joe Thomas.
Joe Thomas
Joe has worked with Strides for over 6 years and has over 28 years’ experience in Business
Development, Strategy formulation and Global Marketing Prior to joining Strides, has held many
significant positions in The STC of India, Procter & Gamble Asia Pacific and Bio Serve
Biotechnologies. He brings broad and in-depth domain knowledge in Life Sciences (Pharma
Biotech and OTC Health) and Strategic and General Management expertise. He has held senior
leadership level positions as Regional Director for P&G’s Asia Export Operations in Singapore
and MD/COO Global in Bio Serve India/US. Joe also serves on several Management &
Advisory Boards of start-up firms to help guide their growth strategies.
He is a Post Graduate in Chemistry with a diploma in Foreign Trade. At Strides, Joe leads
initiatives for identifying future value streams and building the capability and capacity to execute
strategic business initiatives.
He is a member of the Global Leadership Council (GLC) of the Company.
2.3 Brief description and nature of the project.
The proposed project will be manufacturing Monoclonal Antibodies and Therapeutic Proteins.
The installed capacity is 18.2 kg per month. The proposed project aims to meet the local &
global demand for contract manufacturing. The facility is intended to produce bio-chemicals and
therapeutic proteins on a campaign basis and is designed to meet both USFDA and EU
regulations in addition to the regional requirements of schedule M as per Indian Standards. The
process of manufacturing bio-chemicals and therapeutic proteins are produced from raw
materials like Sodium chloride, Potassium chloride, Sodium phosphate and Potassium phosphate
etc. The industry will mainly concentrate on zero discharge of effluents.
2.4 Need for the project and its importance to the country and/or region.
Products that are of Monoclonal Antibodies and Therapeutic Proteins will be utilized &
manufactured based on the requirement of domestic & export markets.
5
2.5 Export possibility
Products manufactured from this facility will be exported to cater to the requirements of
international market.
2.6 Employment Generation
Man power required for the construction of project building will be employed from nearby
places. Directly around 125 numbers of qualified, skilled and semi-skilled man power will be
recruited both on temporary and permanent basis from nearby places. Thus, the industry provides
an employment opportunity for local people.
6
3. Project Description
3.1. Type of project including interlinked and interdependent project, if any.
Not applicable
3.2. Location with coordinates.
Figure: Areal view of the proposed project site
3.3. Details of alternative sites, considered and the basis of selecting the proposed site
particularly the environmental considerations gone into should be highlighted.
Not applicable
3.4. Size & magnitude of operation
The proposed project envisages the production of following Products:
1. Monoclonal Antibodies
2. Therapeutic proteins
Total quantity: 18.2 kg per month
3.5. Project process details (a schematic diagram/flow chart showing the project layout, components of the project etc.) should be
given.
Process Flow Diagram : Drug- Substance
Raw Material Inputs Waste Output
Bioreactor -2000L
Centrifuge
W. Water: 1600 L
Step 1
Fermentation
Media - 32Kg
Glucose- 6400g
Sodium bicarbonate -3200g
Pluronic F68 -1600g
L-Glutamine - 480g
Water- 3600L
Seed Development
(10L – 50L - 200L-500L)
Cell Culture broth – 2000 L.
Protein – 3000gms
Step 2
Centrifugation
NaCl: 4000g
KCl: 100g
Na2HPO4:722g
KH2PO4: 120g
Water: 4000 L
NaCl: 800g
KCl: 20g
Na2HPO4: 144g
KH2PO4: 24g
Water: 3600 L
Cell Debris: 40 Kg
Protein: 2910g
NaCl: 3200g
KCl: 80g
Na2HPO4: 578g
KH2PO4: 96g
Water: 2400L
Working Cell Bank (Vial -l ml)
Media – 8kgs
Water - 400L Waste NIL
Media: Serum free media for
growing mammalian cells
(composition proprietary to the
manufacturer)
8
Lenticular Filtration + 0.2µm sterile
filtration
Purification - Affinity Chromatography
W.Water: 2000 L Step 3
Harvest
NaCl: 800g
KCl: 20g
Na2HPO4:144g
KH2PO4: 24g
Water: 2000 L
Protein: 2851.8g
NaCl: 4000g
KCl: 100g
Na2HPO4:722g
KH2PO4: 120g
Water: 2400 L
Step 4
Purification
NaCl: 112810g
Na2HPO4: 1966g
NaH2PO4: 1074g
Citric acid: 9093g
Sodium Citrate: 20794g
NaOH: 5148g
Ethanol: 44.9Kg
Water: 12000 L
NaCl: 116810g
Na2HPO4: 1796g
NaH2PO4: 1966g
Citric acid: 1714g
Sodium Citrate: 18564g
NaOH: 5148g
Ethanol: 44.9Kg
KCl: 100g
KH2PO4: 120g
Water: 13216 L
Protein: 142.8 g
Protein: 2709 g
Citric acid: 7379g
Sodium Citrate: 2230g
Water: 1184 L
Virus Inactivation W.Water : 1950 L Phosphoric Acid: 985.73g
Tris Base: 1137g
Water: 2000 L
Protein: 2709g
Citric acid: 7379g
Sodium Citrate: 2230g
Phosphoric Acid: 985.73g
Tris Base: 1137 g
Water: 1234 L
9
Lenticular Filtration
NaCl: 432g
Na2HPO4: 78g
KCl: 10.8g
KH2PO4: 13g
Water: 2000 L
Protein: 2709 g
Citric acid: 7379g
Sodium Citrate: 2230g
Phosphoric Acid: 985.73g
Tris Base: 1137g
NaCl: 432g
Na2HPO4: 78g
KCl: 10.8g
KH2PO4: 13g
Water: 1284 L
W.Water: 1950 L
Virus Inactivation
Lenticular Filtration
W.Water: 1950 L
Step 5
Virus Inactivation
Phosphoric Acid: 985.73g
Tris Base: 1137g
Water:2000 L
Protein: 2709g
Citric acid: 7379g
Sodium Citrate: 2230g
Phosphoric Acid: 1971.45g
Tris Base: 2274 gm
Water: 1334 L
Nacl: 432g
Na2HPO4: 78g
Kcl: 10.8g
KH2PO4: 13g
Step 6
Lenticular Filtration
NaCl: 432g
Na2HPO4:78g
KCl: 10.8g
KH2PO4: 13g
Water: 2000 L
W.Water: 1950 L
10
Concentration & Diafiltration
Purification - 2
Anion Exchange Chromatography
Step 7
Concentration &
Diafiltration
HCl: 2906.59g
Tris Base: 8645g
Water: 5000 L
Protein: 2522g
HCl: 581.72g
Tris Base: 1730g
Water: 250 L
Step 8
Purification- 2
Tris Base: 22988g
HCl: 7729.2g
NaCl: 72219g
NaOH: 19000g
Ethanol: 49.77Kg
Water: 8000 L
Tris Base: 21270g
HCl: 7151.54g
NaCl: 55575g
NaOH: 19000g
Ethanol: 49.77Kg
Water: 7680 L
Citric acid: 7379g
Sodium Citrate: 2230 g
Phosphoric Acid: 1154.23g
Tris Base: 8182g
HCl: 2324.86g
NaCl: 432g
Na2HPO4: 278g
KCl: 10.8g
KH2PO4: 13g
Water: 6134 L
Protein: 2471g
Tris Base: 3448g
HCl: 1159.38g
NaCl: 16644g
Water: 570L
Protein: 2655g
Citric acid: 7379g
Sodium Citrate: 2230 g
Phosphoric Acid: 1154.23g
Tris Base: 1137g
NaCl: 432g
Na2HPO4: 278g
KCl: 10.8g
KH2PO4: 13g
Water: 1384 L
11
Viral Filtration
Purification - 3
Cation Exchange Chromatography
Step 9
Viral Filtration
HCl: 61.02g
Tris Base: 181g
Water: 1000 L
Protein: 2347g
HCl: 1362.78g
Tris Base: 3629g
NaCl: 16644g
Water: 600L
Step 10
Purification- 3
Sodium Acetate: 10293g
Acetic acid: 651.43g
Tris Base: 8052g
NaCl: 79192g
NaOH: 10860g
Ethanol: 47.1Kg
Water: 10000 L
Sodium Acetate: 6862g
Acetic acid: 434.29g
HCl: 1464.48g
Tris Base: 3629g
NaCl: 69469g
NaOH: 10860g
Ethanol: 47.1Kg
Water: 9697 L Protein: 2300g
Sodium Acetate: 3431g
Acetic acid: 217.14g
NaCl: 26367g
Water: 903L
W.Water: 970 L
Concentration Step 11
Concentration Water: 4000 L
Protein: 2277g
Sodium Acetate: 562g
Acetic acid: 35.67g
Nacl: 4321g
Water: 200 L
Sodium Acetate: 2869g
Acetic acid: 215.05g
Nacl: 22046g
Water: 4703 L
12
Formulation & Filling facility
Water consumption, KL
Per batch , kl No. of batches Per Month No. of days Per Day
Drug substance facility 58 8 464 25 18.56
Formulation and filling 21.25 15 318.75 25 12.75
Waste water generation, KL
Per batch , kl No. of batches Per Month No. of days Per Day
Drug substance facility 57.972 8 463.776 25 18.551
Formulation and filling 21.25 15 318.75 25 12.75
Step 12
Formulation and
Filling
Sodium Acetate: 197g
Acetic acid: 94.41g
Sorbitol: 10 Kg
Water: 21250 L
Formulation and Filling into vials/
Cartridges/ Prefilled Syringes
W.Water: 21250 L
3.6. Raw material required along with estimated quantity, likely source, marketing area
of final products, mode of transport of raw material and finished products.
Raw materials required, for the production of Monoclonal Antibodies and Therapeutic Proteins
are Sodium chloride, Potassium Chloride, Sodium phosphate, Potassium phosphate, Citric acid,
Sodium Citrate, Tris Base, Sodium Acetate, Sodium Hydroxide, Glucose and Sodium
bicarbonate etc., are procured from the local markets.
A. Raw Materials Availability and Source of Market
Raw material availability and source of marketing will be from local market.
B. Raw Materials Requirement
S. No. Raw Materials Details Quantity per Annum, Kgs.
1 Sodium chloride 3358
2 Potassium Chloride 3
3 Sodium phosphate 80
4 Potassium phosphate 3
5 Citric acid 182
6 Sodium Citrate 416
7 Tris Base 659
8 Sodium Acetate 210
9 Sodium Hydroxide 700
10 Glucose 160
11 Sodium bicarbonate 80
12 Pluronic F68 40
13 Protien Free Media 640
14 L-Glutamine 12
15 Sorbitol 200
16 Ethanol 1200
17 Phosphoric Acid 12
18 Acetic Acid 14
19 Hydrochloric acid 210
3.7. Resource optimization/recycling and reuse envisaged in the project, if any, should be
briefly outlined.
The resource that are recycled and reused are shown in the above process details i.e., in material
balance.
14
3.8. Availability of water its source, Energy/power requirement and sources should be
given.
Water Requirement
The main source of water is from Karnataka Water Board,. The unit requires about 150 KLD for
its manufacturing and other activities.
Power Requirement
The Company requires 3500 KVA Electrical power and HSD is used in DG set. The company
also proposes to install 3 no’s DG sets of capacity 1500 KVA which is utilized during emergency
only.
3.9 Quantity of wastes to be generated (liquid and solid) and scheme for their
Management/disposal.
Quantity of water requirement and waste water generated from the proposed project activity is
listed below
ETP will be designed for 60 KLD. Total solid waste generated from the ETP as sludge will be
reused as manure for greenbelt development.
3.10. Schematic representations of the feasibility drawing which give information of EIA
purpose
Not Applicable
Activity Water requirement
KLD
Wastewater Quantity in
KLD
Process Water 31.3 32.0
Washings 10.0 4.5
Boiler/ Cooling tower 79.5 6.9
Domestic 10.0 9.0
RO Reject 15.0 --
Total 145.8 52.4
15
4. Site Analysis
4.1. Connectivity
The project site is located at Plot no: 2-D1, 3rd
Phase Industrial area, Obadenahalli,
Doddaballapur taluk, Bangalore rural district. It is 3.92 Km away from Doddaballapur towards
NW direction. The excess road of the site is connected to Nagadenahalli road which is connected
to NH- 207 in North direction and nearest highway is National Highway-207 at a distance of
1.06 Km towards North direction. Doddaballapur Railway Station is 3.09 Km towards West
direction from the proposed project site. Obadenahalli is at a distance of 0.21 Km towards SW
direction from the project site. Hence, no new routes or alterations are required in this regard.
4.2. Land form, land use and land ownership
The proposed project is located in Obadenahalli village nearer to Doddaballapur taluk. M/s
STELIS Biopharma Pvt. Ltd. has purchased the industrial area plot from KIADB.
4.3. Topography (along with map)
The Doddaballapur taluk is bounded by Tumakuru district on NW direction, Bangalore district
on South direction, Chikkaballapura district is at NE direction and Kolar district on SE direction.
The Doddaballapur lies at a distance of 27.6 kms from the Bangalore rural district. The ground is
mostly of rocky upland, plateau and flat- topped hills at an elevation of about 900m above MSL.
16
Figure: Location of the proposed project site with 10Km radius demarcation on topo sheet
4.4. Existing land use pattern (agriculture, non-agriculture, forest, water bodies (including
area under CRZ), shortest distances from the periphery of the project to periphery of the
forest, national parks, wild life sanctuary, eco sensitive areas, water bodies (distance from, the
HFL of the river)). In case of notified industrial area a copy of the Gazette notification should
be given.
Salient features Distance in Km
Obadenahalli 0.21 (SW)
Doddaballapur Railway Station 3.09 (W)
National Highway- 207 1.06 (N)
17
4.5. Existing Infrastructure
The proposed project is well connected by road. The approach road to the project site is National
Highway- 207. Water supply to the proposed project is from KIADB, in house bore well, outside
purchase. Electrical demand is from KPTCL and DG set will be used during the power cuts &
plant requirements. M/s STELIS Biopharma Pvt. Ltd. has a land comprising of following blocks:
1. Production block - Drug Product Formulation (DP block).
2. Ware house.
3. Utility.
4. Reception & lobby.
5. Canteen.
6. Security & Gate office.
7. Others- ETP, Tank farm area, Electrical substation & Fuel storage etc.
4.6. Climatic data from secondary sources
The climate in Doddaballapur district has max temperature is 33.50C and min. temperature is
150C. The Doddaballapur district receives lowest rainfall is 754 mm.
4.7. Social Infrastructure available
The approach road to the project site is NH- 207 which is in the North direction. KPTCL will
provide electricity to the industrial area & water requirement in the area is utilized from KIADB,
in house bore well & outside purchase. Government Hospital, Police Station, Fire Station,
Schools and Colleges are available at Doddaballapur which is located at 3.92 Km towards NW
direction from the proposed project site.
18
5. Planning
5.1. Planning concept (type of industries, facilities, transportation, etc.,) Town and
Country Planning Development authority classification.
The proposed project is M/s STELIS Biopharma Pvt. Ltd. manufacturing industry. Qualified and
Skilled man power is available in and around Doddaballapur & Bangalore both on permanent
and temporary basis. The company is planning to have good team of employees in all areas.
Looking in to long term planning, company will take all the necessary steps to develop a good
team of work force. The company will provide basic amenities to staff & employees.
The company will organize training classes for all the staff in the areas of Process up gradation,
Quality Control, cost reduction techniques, Environment & Safety aspects etc.
5.2. Population Projection:
Around 125 numbers of Qualified, Skilled and Semi-Skilled persons are employed in the
operation of proposed project. Hence, the population inflation in the area is negligible.
5.3. Land use planning
No. Type of Land Use Land Area in
Sq. mtrs
1 Actual Plinth Coverage (DP &
DS Block, Utilities, etc.) 12773.11
2 Actual Landscape 18849.29
3 Parking Area 1766.00
4 Internal Road 6294.00
5 Internal Pathways 790.60
Total Area 40473.00
5.4. Assessment of infrastructure Demand (Physical & Social).
There will not be any negative effect on the living conditions of people. Due to project activities,
the surrounding areas are expected to improve by way of socio-economic development due to
direct and indirect employment and the project will also lead to supporting utilities by improving
job & business opportunities in the locality.
19
5.5. Amenities/facilities
The company will provide all basic amenities to staff & employees such as Medical Health,
Children education, transport, canteen facility, clothing, family welfare etc. as per policy of the
company.
20
6. Proposed Infrastructure
6.1. Industrial Area (Processing area)
No. Type of Land Use Land Area in Sq.
mtrs.
1 DS Block (Ware House) 3500.00
2 DP Block 4442.70
3 Utility Block 835.11
4 Reception & Lobby 445.00
5 Canteen 881.70
6 Security & Gate Office 172.80
7 Others (ETP, Tank farm area,
Electrical substation & Fuel storage) 2495.80
8 Actual Landscape 18849.29
9 Parking Area 1766.00
10 Internal Road 6294.00
11 Internal Pathways 790.60
Total Area 40473.00
6.2. Residential Area (non-processing area)
No housing is provided with in the proposed project site.
6.3. Green Belt
Green belt with selected perennial plant species like Mango, Sapota, Custered, Coconut, Neem
tree, Lawn etc., are grown in and around the site.
6.4. Social Infrastructure
The proposed project is a located in KIADB industrial area, Obadenahalli village, Doddaballapur
taluk having good infrastructure facility.
6.5. Connectivity Traffic and Transportation Road/Rail/Metro/Water ways etc.
The project site is located in Obadenahalli Village, Doddaballapur taluk, Bangalore. It is 3.92
Km away from Doddaballapur. The approach road to the proposed site is Obadenahalli road at a
21
distance of 0.21 Km towards SW direction and National Highway- 207 is at 1.06 Km in North
direction. Doddaballapur Railway Station is 3.09 Km towards West direction from the proposed
project site. Obadenahalli is well connected to the major destinations by road. Hence, no new
routes or alterations are required in this regard.
6.6. Drinking Water management (Source & Supply of water)
The source of water is from Karnataka Water Board. 10 KLD of water will be utilized for
domestic purpose.
6.7. Sewerage System
About 9 KLD of waste water is generated from domestic purpose which is sent to the septic tank
to soak pit.
6.8. Industrial waste management
The industry shall adopt and follow an environmental management plan for abatement of
pollution and overall enhancement of the quality of environment in and around the unit. It is
mainly concentrating for zero discharge of effluents is concerned.
Treated effluent will be reused for green belt development and ETP sludge will be utilized as
manure for green belt development.
6.9. Solid waste management
Solid waste shall collected & stored in HDPE drums and disposed to TSDF facility.
6.10. Power requirement & Supply/Source
The company requires 3500 KVA power for the proposed project and it will be arranged by
KPTCL. The company is also proposing to install 3 no’s of DG sets with 1500 KVA capacity as
standby which is utilized during emergency only.
22
7. Rehabilitation and Resettlement (R&R) Plan
7.1. Policy to be adopted (Central/State) in respect of the project affected persons
including home oustees, land oustees, and landless labourers (a brief outline to be given).
Not applicable, since M/s STELIS Biopharma Pvt. Ltd. has purchased the property in KIADB
industrial area from KIADB for manufacturing Monoclonal Antibodies and Therapeutic
Proteins.
23
8. Project Schedule & Cost Estimation
8.1. Project Schedule
The company is planning to procure ancillary machinery and have its trial production in June,
2017. The commercial production is planned to start from Aug 2017.
8.2. Cost Estimates
The estimated cost of the project is Rs. 248 Crores. Investment breakups of the proposed project
are tabulated below:
Description Amount ( In Rs. in Lakhs )
Land & Building 680
Plant and Machinery 1550
Working capital margin & Contingencies 160
Capital Investment 2480
24
9. Analysis of proposal (Final recommendation)
9.1. Financial and social benefits with special emphasis on the benefit to the local people
including tribal population, if any, in the area.
Qualified and skilled man power is available in nearby places, both on temporary and permanent
basis.
The company is planning to have good team of employees in all areas. Looking in to long term
planning, company will take all the necessary steps to develop a good team of work force. The
company will provide all basic amenities to staff & employees such as Medical Health, Children
education, transport, canteen facility, clothing, family welfare etc. as per policy of the company.
The company will organize training classes for all the staff in the areas of process up gradation,
quality control, cost reduction techniques, environmental safety, etc.